MODIVCARE INC (MODV)

US60783X1046 - Common Stock

32  +0.62 (+1.98%)

After market: 32 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MODV. MODV was compared to 114 industry peers in the Health Care Providers & Services industry. MODV may be in some trouble as it scores bad on both profitability and health. MODV has a correct valuation and a medium growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year MODV was profitable.
In the past year MODV has reported a negative cash flow from operations.
MODV had negative earnings in 4 of the past 5 years.
In multiple years MODV reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a Return On Assets value of -9.59%, MODV is not doing good in the industry: 67.54% of the companies in the same industry are doing better.
The Return On Equity of MODV (-1689.29%) is worse than 85.09% of its industry peers.
MODV has a Return On Invested Capital (1.82%) which is in line with its industry peers.
MODV had an Average Return On Invested Capital over the past 3 years of 3.11%. This is below the industry average of 7.76%.
Industry RankSector Rank
ROA -9.59%
ROE -1689.29%
ROIC 1.82%
ROA(3y)-4.51%
ROA(5y)-2.36%
ROE(3y)-47.21%
ROE(5y)-26.92%
ROIC(3y)3.11%
ROIC(5y)4.49%

1.3 Margins

MODV has a Operating Margin (1.07%) which is comparable to the rest of the industry.
MODV's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 15.73%, MODV is not doing good in the industry: 68.42% of the companies in the same industry are doing better.
MODV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.07%
PM (TTM) N/A
GM 15.73%
OM growth 3Y-46.23%
OM growth 5Y-13.75%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.58%
GM growth 5Y18.19%

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MODV is destroying value.
MODV has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for MODV has been increased compared to 5 years ago.
Compared to 1 year ago, MODV has a worse debt to assets ratio.

2.2 Solvency

MODV has an Altman-Z score of 1.65. This is a bad value and indicates that MODV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.65, MODV is in line with its industry, outperforming 45.61% of the companies in the same industry.
A Debt/Equity ratio of 122.86 is on the high side and indicates that MODV has dependencies on debt financing.
The Debt to Equity ratio of MODV (122.86) is worse than 85.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 122.86
Debt/FCF N/A
Altman-Z 1.65
ROIC/WACC0.26
WACC7%

2.3 Liquidity

MODV has a Current Ratio of 0.80. This is a bad value and indicates that MODV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.80, MODV is doing worse than 80.70% of the companies in the same industry.
A Quick Ratio of 0.80 indicates that MODV may have some problems paying its short term obligations.
MODV's Quick ratio of 0.80 is on the low side compared to the rest of the industry. MODV is outperformed by 72.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8

4

3. Growth

3.1 Past

MODV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.51%.
The Earnings Per Share has been growing by 17.87% on average over the past years. This is quite good.
MODV shows a small growth in Revenue. In the last year, the Revenue has grown by 4.11%.
The Revenue has been growing by 14.71% on average over the past years. This is quite good.
EPS 1Y (TTM)-60.51%
EPS 3Y-6.06%
EPS 5Y17.87%
EPS Q2Q%-102.04%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y26.2%
Revenue growth 5Y14.71%
Sales Q2Q%-0.12%

3.2 Future

MODV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.19% yearly.
The Revenue is expected to grow by 5.16% on average over the next years.
EPS Next Y-61.56%
EPS Next 2Y-7.1%
EPS Next 3Y5.19%
EPS Next 5YN/A
Revenue Next Year2.71%
Revenue Next 2Y5.05%
Revenue Next 3Y5.16%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.26, the valuation of MODV can be described as correct.
Based on the Price/Earnings ratio, MODV is valued cheaply inside the industry as 91.23% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 29.62. MODV is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 6.60, which indicates a rather cheap valuation of MODV.
Based on the Price/Forward Earnings ratio, MODV is valued cheaply inside the industry as 99.12% of the companies are valued more expensively.
MODV is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.22, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.26
Fwd PE 6.6

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MODV is valued a bit cheaper than 79.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.36

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.69
EPS Next 2Y-7.1%
EPS Next 3Y5.19%

0

5. Dividend

5.1 Amount

MODV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MODIVCARE INC

NASDAQ:MODV (9/6/2024, 8:00:02 PM)

After market: 32 0 (0%)

32

+0.62 (+1.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap454.72M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.26
Fwd PE 6.6
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA -9.59%
ROE -1689.29%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.07%
PM (TTM) N/A
GM 15.73%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 122.86
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-60.51%
EPS 3Y-6.06%
EPS 5Y
EPS Q2Q%
EPS Next Y-61.56%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.11%
Revenue growth 3Y26.2%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y